ARCHIVES

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

This article is from The Cancer Letter archive.

Vol. 25 No. 21 | May 28, 1999

Download PDF Visit The Full Archive

Related Articles

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

NCCS Networker Volume 2 Issue 3, Summer 1988

June 13, 1988

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

April 29, 2011

Cooperative Groups: Decision To Form One Group Seemed “So Obvious”

August 7, 1998